HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoimmune hemolytic anemia.

Abstract
A 19-year-old female was admitted with general malaise and systemic edema. She had been diagnosed as having autoimmune hemolytic anemia (AIHA) eight years earlier and was successfully managed with oral prednisolone. During the current admission, she was diagnosed as having systemic lupus erythematosus (SLE) based on the presence of renal involvement, hematological abnormalities, and antinuclear and anti-double-stranded DNA antibodies, along with a recurrence of AIHA; her serology revealed a high myeloperoxydase-antineutrophil cytoplasmic antibody (MPO-ANCA) titer. She was treated with prednisolone (50 mg day(-1)), but her renal function started to deteriorate. She responded to treatment with hemodialysis, plasmapheresis, and methylprednisolone pulse therapy; her MPO-ANCA titer and renal function improved. Treatment with intravenous cyclophosphamide gradually suppressed her AIHA and SLE activity. A renal biopsy revealed a diffuse proliferative lupus nephritis (class IV-G (A)) with necrotizing crescentic glomerulonephritis that was presumed to be associated with MPO-ANCA. The association of MPO-ANCA with SLE in this refractory case is discussed.
AuthorsYuki Hirai, Masayuki Iyoda, Takanori Shibata, Eijin Ashikaga, Nozomu Hosaka, Hiroki Suzuki, Hisako Nagai, Masanori Mukai, Hirokazu Honda, Aki Kuroki, Kozo Kitazawa, Tadao Akizawa
JournalClinical and experimental nephrology (Clin Exp Nephrol) Vol. 12 Issue 5 Pg. 393-397 (Oct 2008) ISSN: 1342-1751 [Print] Japan
PMID18465193 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Antineutrophil Cytoplasmic
  • Peroxidase
Topics
  • Adult
  • Anemia, Hemolytic, Autoimmune (blood)
  • Antibodies, Antineutrophil Cytoplasmic (blood)
  • Biopsy
  • Female
  • Humans
  • Kidney Glomerulus (pathology)
  • Lupus Nephritis (blood, diagnosis)
  • Peroxidase (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: